TRAIL As Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases
Overview
Affiliations
This review focuses on TNF-related apoptosis-inducing ligand (TRAIL), also called Apo2 ligand, a protein belonging to the TNF superfamily. TRAIL can be found either in its transmembrane or circulating form, and its mostly studied peripheral effect is the induction of cellular apoptosis. Here, we discuss the evidences supporting the use of TRAIL as biomarker of cardiovascular diseases as well as the evidences showing the potential beneficial therapeutic effects of TRAIL on cardiovascular diseases and diabetes.
Sergi D, Zauli E, Casciano F, Secchiero P, Zauli G, Fields M Antioxidants (Basel). 2022; 11(12).
PMID: 36552548 PMC: 9774631. DOI: 10.3390/antiox11122340.
Rhedin S, Elfving K, Berggren A Children (Basel). 2021; 8(11).
PMID: 34828783 PMC: 8623137. DOI: 10.3390/children8111070.
Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis.
Remuzgo-Martinez S, Genre F, Lopez-Mejias R, Ubilla B, Mijares V, Pina T Sci Rep. 2016; 6:29713.
PMID: 27403809 PMC: 4940734. DOI: 10.1038/srep29713.
Sambandam Y, Baird K, Stroebel M, Kowal E, Balasubramanian S, Reddy S Sci Rep. 2016; 6:25143.
PMID: 27142480 PMC: 4855152. DOI: 10.1038/srep25143.
Soluble TRAIL Concentration in Serum Is Elevated in People with Hypercholesterolemia.
Cheng W, Liu F, Wang Z, Zhang Y, Zhao Y, Zhang Q PLoS One. 2015; 10(12):e0144015.
PMID: 26633016 PMC: 4669162. DOI: 10.1371/journal.pone.0144015.